JPH09176075A - Antimicrobial, antifungal and anti-inflammatory active substance and production thereof - Google Patents

Antimicrobial, antifungal and anti-inflammatory active substance and production thereof

Info

Publication number
JPH09176075A
JPH09176075A JP34292495A JP34292495A JPH09176075A JP H09176075 A JPH09176075 A JP H09176075A JP 34292495 A JP34292495 A JP 34292495A JP 34292495 A JP34292495 A JP 34292495A JP H09176075 A JPH09176075 A JP H09176075A
Authority
JP
Japan
Prior art keywords
guaiacol
antifungal
peroxidase
polymer
hydrogen peroxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP34292495A
Other languages
Japanese (ja)
Inventor
Akio Kobayashi
昭雄 小林
Masahiro Hiraki
雅弘 平木
Takeshi Baba
健史 馬場
Shinichiro Kajiyama
慎一郎 梶山
Hiroshi Kanzaki
浩 神崎
Kazuyoshi Kawazu
一儀 河津
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kibun Foods Inc
Original Assignee
Kibun Foods Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kibun Foods Inc filed Critical Kibun Foods Inc
Priority to JP34292495A priority Critical patent/JPH09176075A/en
Publication of JPH09176075A publication Critical patent/JPH09176075A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the above polymer exhibiting antimicrobial, antifungal, anti-inflammatory and antioxidizing activity and useful also as a pigment or dye by polymerizing guaiacol using peroxidase in the presence of hydrogen peroxide. SOLUTION: (A) Guaiacol is polymerized using (C) peroxidase in the presence of (B) hydrogen peroxide to provide the objective polymer excluding a compound of formula I, preferably a polymer of formula II, etc. Furthermore, the reaction is carried out in 1×10<-5> to 1×10<-4> mol/mg concentration of the component B in a buffer solution such as sodium phosphate at about 25 deg.C and crude enzyme, etc., prepared from horseradish, etc., is preferably used as the component C.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本明細書にて開示する発明
は、抗菌・抗カビまたは抗炎症活性物質、その製造方
法、および抗菌・抗カビまたは抗炎症剤に関する。
TECHNICAL FIELD The present invention disclosed herein relates to an antibacterial / antifungal or anti-inflammatory active substance, a method for producing the same, and an antibacterial / antifungal or anti-inflammatory agent.

【0002】[0002]

【従来の技術】植物は微生物の侵入に対してさまざまな
誘導抵抗反応を示すことが知られている。これは、遺伝
子的に制御されたさまざまな酵素の働きによるものであ
る。ペルオキシダーゼは、そのような誘導抵抗反応の発
現を活性化する酵素の1つであり、フェノール性化合物
を修飾・重合する作用を有することが知られている。し
かしながら、ペルオキシダーゼの働きによって生成する
化合物がいかなる構造を有する化合物であって、それが
どの程度の化学的・生理学的作用を示すのかという点に
ついては、いまだ十分に解明されていない。
2. Description of the Related Art It is known that plants show various induced resistance reactions to invasion of microorganisms. This is due to the action of various genetically regulated enzymes. Peroxidase is one of the enzymes that activates the expression of such induced resistance reaction, and is known to have an action of modifying and polymerizing a phenolic compound. However, the structure of the compound produced by the action of peroxidase and the degree of chemical / physiological action of the compound have not yet been sufficiently clarified.

【0003】[0003]

【発明が解決しようとする課題】そこで、本発明者ら
は、フェノール性化合物であるグアイアコールにペルオ
キシダーゼを作用させて得られる化合物の分析を行うこ
とによって、従来にない新規な抗菌・抗カビおよび抗炎
症活性物質を提供することを目的として検討を進め、本
明細書に開示する発明をなすに至った。
Therefore, the present inventors analyzed the compound obtained by allowing peroxidase to act on guaiacol, which is a phenolic compound, to analyze a novel antibacterial / antifungal and antifungal agent which has not been heretofore available. Investigations have been advanced for the purpose of providing an inflammatory active substance, and the invention disclosed in the present specification has been achieved.

【0004】[0004]

【課題を解決するための手段】本明細書において、グア
イアコールまたはグアイアコール重合体を過酸化水素の
存在下でペルオキシダーゼと反応させる発明を開示す
る。
SUMMARY OF THE INVENTION Disclosed herein is an invention in which guaiacol or a guaiacol polymer is reacted with peroxidase in the presence of hydrogen peroxide.

【0005】この反応において出発物質として用いるグ
アイアコールまたはグアイアコール重合体は、市販され
ているものであっても合成されたものであってもよい。
また、グアイアコール重合体は、本明細書に開示される
方法にしたがって取得したものであっても、他の方法に
よって取得したものであってもよい。通常は、二量体や
三量体を用いる。このようなグアイアコール重合体を出
発物質として用いることによって、重合度の高い重合体
を簡便な方法で効率よく取得することが可能になる。例
えば、出発物質としてグアイアコール三量体を用いた場
合は、グアイアコール六量体を効率よく取得することが
できる。出発物質であるグアイアコールやグアイアコー
ル重合体は、単独で使用してもよいし複数種を組み合わ
せて使用してもよい。なお、ペルオキシダーゼとの反応
に悪影響を及ぼさないものであれば、反応時に他の物質
が共存していてもよい。
The guaiacol or guaiacol polymer used as a starting material in this reaction may be commercially available or synthesized.
In addition, the guaiacol polymer may be obtained according to the method disclosed herein or may be obtained by other methods. Usually, dimers and trimers are used. By using such a guaiacol polymer as a starting material, a polymer having a high degree of polymerization can be efficiently obtained by a simple method. For example, when guaiacol trimer is used as a starting material, guaiacol hexamer can be efficiently obtained. The guaiacol or guaiacol polymer as a starting material may be used alone or in combination of two or more kinds. Other substances may coexist during the reaction as long as they do not adversely affect the reaction with peroxidase.

【0006】この反応で用いるペルオキシダーゼの種類
はとくに制限されない。したがって、西洋わさびやイン
ゲンなどから調製された粗酵素や商業的に入手できるも
のを用いることができる。
The type of peroxidase used in this reaction is not particularly limited. Therefore, a crude enzyme prepared from horseradish, green beans, or the like or a commercially available enzyme can be used.

【0007】グアイアコールとペルオキシダーゼとの反
応は、過酸化水素の存在下で行う。過酸化水素の濃度
は、通常1mgあたり1x10-5mol〜1x10-4
olとするが、この範囲外の濃度であっても反応は実施
しうる。また、反応は緩衝液中で行ってもよい。緩衝液
としては、例えばリン酸ナトリウム緩衝液やトリス−塩
酸緩衝液を用いることができる。反応温度は、ペルオキ
シダーゼが活性を示す温度とすることができるが、通常
は25℃前後で行う。反応時間を長くしたり、濃度を高
めたりすることによって、活性が高い物質を製造するこ
とができる。なお、反応の進行は適当な展開液を用いて
TLCにより追跡することができる。
The reaction between guaiacol and peroxidase is carried out in the presence of hydrogen peroxide. The concentration of hydrogen peroxide is usually 1 × 10 −5 mol to 1 × 10 −4 m per 1 mg.
However, the reaction can be carried out at a concentration outside this range. In addition, the reaction may be performed in a buffer solution. As the buffer solution, for example, sodium phosphate buffer solution or Tris-hydrochloric acid buffer solution can be used. The reaction temperature may be a temperature at which peroxidase is active, but it is usually about 25 ° C. By increasing the reaction time or increasing the concentration, a substance with high activity can be produced. The progress of the reaction can be followed by TLC using an appropriate developing solution.

【0008】反応生成物は、粗生成物のままでも抗菌・
抗カビ、抗炎症または抗酸化活性を示すことから、さら
に精製することなく粗生成物のままこれらの用途に用い
ることができる。しかし、粗生成物の中には活性が特に
強い化合物とそうでない化合物が混在しているため、特
に活性の強い化合物を精製して使用するのが好ましい。
精製は、カラムクロマトグラフィー、逆相カラムクロマ
トグラフィー、分取HPLCなどの当業者に周知の方法
によって行うことができる。本発明者らは、粗生成物中
に含まれる複数の化合物を単離することによって、以下
に示す構造を有するグアイアコール重合体を見いだし
た。これらの化合物は、いずれも新規化合物である。
The reaction product is antibacterial even if it is a crude product.
Since it exhibits antifungal, anti-inflammatory or antioxidant activity, it can be used in these applications as a crude product without further purification. However, since compounds having particularly strong activity and compounds not having such activity coexist in the crude product, it is preferable to purify and use the compound having particularly strong activity.
Purification can be performed by methods well known to those skilled in the art, such as column chromatography, reverse phase column chromatography, preparative HPLC and the like. The present inventors discovered a guaiacol polymer having the structure shown below by isolating a plurality of compounds contained in the crude product. All of these compounds are novel compounds.

【0009】[0009]

【化3】 これらの化合物は、いずれも抗菌・抗カビ、抗炎症、抗
酸化活性を示すものである。グアイアコール二量体やグ
アイアコール三量体には、優れた活性が見いだされてい
る。特に、グアイアコール三量体は顕著なうに胚分裂阻
害活性を示し、2μg/mlで完全にうに胚の分裂を阻
害することが確認されている。また、グアイアコール重
合体の中には良好な色を有しているものもあり、色素や
染料としての用途も期待しうる。
Embedded image All of these compounds exhibit antibacterial / antifungal, anti-inflammatory and antioxidant activities. Excellent activity has been found in guaiacol dimers and guaiacol trimers. In particular, it has been confirmed that guaiacol trimer shows a remarkable urinary mitotic inhibitory activity and completely inhibits urinary mitotic division at 2 μg / ml. Further, some guaiacol polymers have a good color, and can be expected to be used as pigments and dyes.

【0010】[0010]

【実施例】以下に実施例を挙げて、本発明を具体的に説
明するが、本発明の技術的範囲はこれらの実施例によっ
て何ら制限的に解釈されるものではない。
EXAMPLES The present invention will be specifically described below with reference to examples, but the technical scope of the present invention is not limited to these examples.

【0011】(実施例1)グアイアコール8mgおよび
0.35%過酸化水素水80mlを0.1Mトリス塩酸
緩衝液(pH8.0)4リットルに懸濁し、西洋わさび
より調製したペルオキシダーゼ(ナカライ製、PEO−
131:I−C級)40,000ユニット(東洋紡の定
義による)を加えて、25℃で15分間反応させた。そ
の後、酢酸エチルで抽出して、抽出物7.99gを得
た。これをオープンカラム(Wakogel C−10
0;10%H2O;φ3.6x30cm)により精製し
た。溶出液として、酢酸エチルの濃度を徐々に上げたヘ
キサン溶液を用いて、20%酢酸エチル溶液の画分から
粗生成物29mg、23〜30%酢酸エチル溶液の画分
から粗生成物368mg、33〜37%酢酸エチル溶液
の画分から粗生成物250mgを得た。23〜30%酢
酸エチル溶液の画分から得た粗生成物368mgを、中
圧カラム(Millipore Preparativ
e C18;φ1.0x100cm;0.5ml/mi
n)によりメタノール/水混合物で溶出することによっ
て二量体Aを得た。20%酢酸エチル溶液の画分から得
た粗生成物29mgは単品であったので二量体Bとし
た。33−37%酢酸エチル溶液から得た粗生成物25
0mgを中圧カラム(Millipore Prepa
rative C18;φ1.0x100cm;0.5
ml/min)によりメタノール/水混合物で溶出する
ことによって、順に三量体A(8.5mg)、四量体A
(2.5mg)および四量体Bを得た。
(Example 1) 8 mg of guaiacol and 80 ml of 0.35% hydrogen peroxide were suspended in 4 liters of 0.1 M Tris-hydrochloric acid buffer (pH 8.0), and peroxidase prepared from horseradish (NAO, PEO). −
131: IC class) 40,000 units (as defined by Toyobo) were added and reacted at 25 ° C. for 15 minutes. Then, it was extracted with ethyl acetate to obtain 7.99 g of an extract. This is an open column (Wakogel C-10
0; 10% H 2 O; φ3.6 × 30 cm). Using a hexane solution in which the concentration of ethyl acetate was gradually increased as an eluent, 29 mg of a crude product from a fraction of a 20% ethyl acetate solution, 368 mg of a crude product from a fraction of a 23 to 30% ethyl acetate solution, 33 to 37 were used. A crude product of 250 mg was obtained from the fraction of a% ethyl acetate solution. 368 mg of the crude product obtained from the fraction of a 23-30% ethyl acetate solution was applied to a medium pressure column (Millipore Preparative).
e C18; φ1.0 × 100 cm; 0.5 ml / mi
Dimer A was obtained by elution with a methanol / water mixture according to n). The crude product (29 mg) obtained from the fraction of the 20% ethyl acetate solution was a single product, and was designated as dimer B. 33-37% crude product obtained from 37% ethyl acetate solution
0 mg to a medium pressure column (Millipore Prepa
ratio C18; φ1.0x100cm; 0.5
(ml / min) by elution with a methanol / water mixture to give trimer A (8.5 mg) and tetramer A
(2.5 mg) and tetramer B were obtained.

【0012】これらの化合物の同定データは以下のとお
りであった。なお、四量体AおよびBはMS分析の結
果、四量体であることが明らかにされた。
The identification data of these compounds are as follows. The tetramers A and B were found to be tetramers as a result of MS analysis.

【0013】[二量体A] NMR δH(500MHz,アセトン−d6):3.8
5(6H,s),6.83(2H,d,J=7.6H
z),6.84(2H,d,J=2.1Hz),6.9
2(2H,dd,J=2.1,7.6Hz) EI MS m/z:246(M+
[Dimer A] NMR δ H (500 MHz, acetone-d 6 ): 3.8
5 (6H, s), 6.83 (2H, d, J = 7.6H
z), 6.84 (2H, d, J = 2.1 Hz), 6.9.
2 (2H, dd, J = 2.1, 7.6 Hz) EI MS m / z: 246 (M + ).

【化4】 [二量体B] NMR δH(500MHz,CDCl3):3.82
(3H,s),3.84(3H,s),5.39(1
H,s),6.46(1H,dd,J=2.5,9.0
Hz),6.65(1H,d,J=2.5Hz),6.
83(1H,d,J=9.0Hz),6.85−6.9
0(2H,m),6.99(1H,d,J=7.9H
z),7.06(1H,ddd,J=2.3,6.7H
z) EI MS m/z:246(M+
Embedded image [Dimer B] NMR δ H (500 MHz, CDCl 3 ): 3.82
(3H, s), 3.84 (3H, s), 5.39 (1
H, s), 6.46 (1H, dd, J = 2.5, 9.0)
Hz), 6.65 (1H, d, J = 2.5 Hz), 6.
83 (1H, d, J = 9.0 Hz), 6.85-6.9.
0 (2H, m), 6.99 (1H, d, J = 7.9H
z), 7.06 (1H, ddd, J = 2.3, 6.7H
z) EI MS m / z: 246 (M + ).

【化5】 [三量体A] NMR δH(500MHz,CDCl3):3.86
(3H,s),3.94(3H,s),3.96(3
H,s),5.36(1H,s),5.65(1H,
s),6.49(1H,dd,J=2.8,8.5H
z),6.68(1H,d,J=2.8Hz),6.8
5(1H,d,J=8.5Hz),6.90(1H,
d,J=8.2Hz),6.98(1H,d,J=8.
2Hz),7.03(1H,dd,J=2.1,8.2
Hz),7.04(1H,d,J=2.1Hz),7.
08(1H,dd,J=2.1,8.2Hz),7.1
3(1H,d,J=2.1Hz) API MS m/z:369(M+H)+
Embedded image [Trimer A] NMR δ H (500 MHz, CDCl 3 ): 3.86
(3H, s), 3.94 (3H, s), 3.96 (3
H, s), 5.36 (1H, s), 5.65 (1H,
s), 6.49 (1H, dd, J = 2.8, 8.5H
z), 6.68 (1H, d, J = 2.8 Hz), 6.8
5 (1H, d, J = 8.5Hz), 6.90 (1H,
d, J = 8.2 Hz), 6.98 (1H, d, J = 8.
2 Hz), 7.03 (1H, dd, J = 2.1, 8.2
Hz), 7.04 (1H, d, J = 2.1 Hz), 7.
08 (1H, dd, J = 2.1, 8.2Hz), 7.1
3 (1H, d, J = 2.1 Hz) API MS m / z: 369 (M + H) +

【化6】 (実施例2)以下の式:[Chemical 6] Example 2 The following formula:

【化7】 で表されるグアイアコール三量体(三量体B)45mg
および0.35%過酸化水素水4.0mlを0.1Mト
リス塩酸緩衝液(pH8.0)450mlに懸濁し、西
洋わさびより調製したペルオキシダーゼ(ナカライ製、
PEO−131:I−C級)14,000ユニット(東
洋紡の定義による)を加えて、25℃で15分間反応さ
せた。得られた粗生成物にメタノールを添加して酵素を
不活性化した後、MALDI TOF MSスペクトルを
測定した。結果は図1に示すとおりであった。
Embedded image Guaiacol trimer represented by (trimer B) 45mg
And 4.0 ml of 0.35% hydrogen peroxide solution were suspended in 450 ml of 0.1 M Tris-HCl buffer (pH 8.0), and peroxidase prepared from horseradish (Nacalai,
PEO-131: I-C grade) 14,000 units (as defined by Toyobo) was added and reacted at 25 ° C for 15 minutes. Methanol was added to the obtained crude product to inactivate the enzyme, and then MALDI TOF MS spectrum was measured. The results were as shown in FIG.

【0014】混合物をクロロホルムで抽出して溶媒を留
去することによって、45mgの固形物を得た。これを
0.1N塩酸中にて亜鉛存在下で還元し、クロロホルム
を用いて抽出した。クロロホルム層の溶媒を留去して、
固形物44mgを得た。さらにこれを調製TLC(溶媒
系はクロロホルム:メタノール=100:2)によって
精製し、Rf=0.34のグアイアコール六量体A4.
8mgとRf=0.50のグアイアコール六量体B2.
7mgを得た。これらの同定データは以下のとおりであ
った。
The mixture was extracted with chloroform and the solvent was distilled off to obtain 45 mg of a solid substance. This was reduced in 0.1N hydrochloric acid in the presence of zinc, and extracted with chloroform. The solvent of the chloroform layer was distilled off,
44 mg of solid was obtained. This was further purified by preparative TLC (solvent system: chloroform: methanol = 100: 2), and guaiacol hexamer A4.
8 mg and Rf = 0.50 guaiacol hexamer B2.
7 mg were obtained. These identification data were as follows.

【0015】[六量体A] NMR δH(500MHz,CDCl3):3.92
(6H,s),3.97(6H,s),3.99(6
H,s),6.95(2H,d,J=8.2Hz),
6.99(2H,d,J=2.1Hz),7.02(2
H,d,J=1.8Hz),7.05(2H,dd,J
=1.8,8.2Hz),7.14(2H,d,J=
2.1Hz),7.26(2H,d,J=2.1H
z),7.29(2H,d,J=2.1) API MS m/z:735(M+H)+ [六量体B] API MS m/z:735(M+H)+ プロトン−プロトンCOSYでABX系が3組存在する
ことが判明した。
[Hexamer A] NMR δ H (500 MHz, CDCl 3 ): 3.92
(6H, s), 3.97 (6H, s), 3.99 (6
H, s), 6.95 (2H, d, J = 8.2Hz),
6.99 (2H, d, J = 2.1Hz), 7.02 (2
H, d, J = 1.8 Hz), 7.05 (2H, dd, J
= 1.8, 8.2 Hz), 7.14 (2H, d, J =
2.1 Hz), 7.26 (2H, d, J = 2.1H
z), 7.29 (2H, d, J = 2.1) API MS m / z: 735 (M + H) + [hexamer B] API MS m / z: 735 (M + H) + proton-proton in COZY. It was found that there are three ABX lines.

【0016】(実施例3)実施例2の出発物質であるグ
アイアコール三量体Bの代わりに、以下の式:
Example 3 Instead of the starting material guaiacol trimer B of Example 2, the following formula:

【化8】 で表されるグアイアコール二量体Cを用いて同様の反応
を行った。
Embedded image A similar reaction was performed using guaiacol dimer C represented by

【0017】(実施例4)グアイアコール二量体Aおよ
びC、三量体AおよびB、四量体AおよびB、および六
量体AおよびBについて、抗カビ活性とうに胚分裂阻害
活性をそれぞれ比較した。
(Example 4) The guaiacol dimers A and C, the trimers A and B, the tetramers A and B, and the hexamers A and B were compared in antifungal activity and embryonic division inhibitory activity, respectively. did.

【0018】抗カビ活性は、クラドスポリウム ハーバ
ラム(Cladosporiumherbarum)を
用いて試験した。この胞子を胞子発芽用培地(グルコー
ス0.2%、イーストエキストラクト0.1%、NaH
PO4・12H2O 0.37%、クエン酸0.1%)に
懸濁し、それぞれ試料濃度を1000μg/ml、50
0μg/ml、250μg/ml、125μg/ml、
63μg/mlとして27℃で培養し、24時間後に胞
子の発芽が認められるか否かを顕微鏡で観察した。
The antifungal activity was tested using Cladosporium herbarum. The spores were spore germination medium (glucose 0.2%, yeast extract 0.1%, NaH
PO 4 .12H 2 O 0.37%, citric acid 0.1%) and suspended at sample concentrations of 1000 μg / ml and 50, respectively.
0 μg / ml, 250 μg / ml, 125 μg / ml,
It was cultured at 27 ° C. as 63 μg / ml, and after 24 hours, it was observed under a microscope whether spore germination was observed.

【0019】うに胚分裂阻害活性試験に用いた卵と精液
は、繁殖期(1−3月)に岡山で収集した性成熟ウニ
Hemicentrotus pulcherrim
us)から取り出した。卵は撹拌して3分間静置し、表
面と底にある卵をそれぞれ傾斜法と吸引法により除去し
たものを用いた。連続希釈試料溶液に約100個の受精
卵を添加し、胚の形態変化を観察することによって、植
物抽出物の細胞毒性を評価した。
Eggs and semen used for the sea urchin embryo inhibitory activity test were sexually mature sea urchins ( Hemicentrotus pulcherrim ) collected in Okayama during the breeding season (January-March).
us )). The eggs were stirred and allowed to stand for 3 minutes, and the eggs on the surface and the bottom were removed by the tilting method and the suction method, respectively. The cytotoxicity of the plant extract was evaluated by adding about 100 fertilized eggs to the serially diluted sample solution and observing the morphological change of the embryo.

【0020】結果は、図2に示すとおりであった。The results are shown in FIG.

【図面の簡単な説明】[Brief description of the drawings]

【図1】グアイアコールと、グアイアコール三量体にペ
ルオキシダーゼを反応させて得られた粗生成物のMAL
DI TOF MSスペクトルである。
FIG. 1 MAL of a crude product obtained by reacting guaiacol and a guaiacol trimer with peroxidase.
It is a DI TOF MS spectrum.

【図2】グアイアコール二量体、三量体、四量体および
六量体の抗カビ活性とうに胚分裂阻害活性を示すグラフ
である。
FIG. 2 is a graph showing the antifungal activity of guaiacol dimers, trimers, tetramers and hexamers, as well as the embryonic division inhibitory activity.

フロントページの続き (72)発明者 梶山 慎一郎 大阪府高槻市日吉台4番町1912 (72)発明者 神崎 浩 岡山県岡山市津島桑の木町1−17 (72)発明者 河津 一儀 岡山県岡山市宿本町8−51−12Front page continuation (72) Inventor Shinichiro Kajiyama 1912 Hiyoshidai 4th Town, Takatsuki City, Osaka Prefecture 1212 (72) Inventor Hiroshi Kanzaki 1-17 Tsuwawamachi, Tsushima Okayama City, Okayama Prefecture (72) Ikki Kawazu Okayama Prefecture, Okayama Prefecture Ichijuku Honmachi 8-51-12

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】グアイアコールを過酸化水素の存在下でペ
ルオキシダーゼを用いて重合させることによって得られ
るグアイアコール重合体(ただし、式: 【化1】 で表される化合物を除く)。
1. A guaiacol polymer obtained by polymerizing guaiacol with peroxidase in the presence of hydrogen peroxide (wherein the formula: Excluding compounds represented by).
【請求項2】以下の式: 【化2】 で表されるグアイアコール重合体。2. The following formula: A guaiacol polymer represented by. 【請求項3】グアイアコールを過酸化水素の存在下でペ
ルオキシダーゼを用いて重合させる工程を含む、請求項
2のグアイアコール重合体の製造方法。
3. The method for producing a guaiacol polymer according to claim 2, which comprises a step of polymerizing guaiacol using peroxidase in the presence of hydrogen peroxide.
【請求項4】グアイアコール重合体を過酸化水素の存在
下でペルオキシダーゼを用いて重合させる工程を含む、
抗菌・抗カビまたは抗炎症活性物質の製造方法。
4. A step of polymerizing a guaiacol polymer with peroxidase in the presence of hydrogen peroxide,
A method for producing an antibacterial / antifungal or anti-inflammatory active substance.
【請求項5】請求項2のグアイアコール重合体を含有す
る抗菌・抗カビまたは抗炎症剤。
5. An antibacterial / antifungal or anti-inflammatory agent containing the guaiacol polymer of claim 2.
JP34292495A 1995-12-28 1995-12-28 Antimicrobial, antifungal and anti-inflammatory active substance and production thereof Pending JPH09176075A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP34292495A JPH09176075A (en) 1995-12-28 1995-12-28 Antimicrobial, antifungal and anti-inflammatory active substance and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34292495A JPH09176075A (en) 1995-12-28 1995-12-28 Antimicrobial, antifungal and anti-inflammatory active substance and production thereof

Publications (1)

Publication Number Publication Date
JPH09176075A true JPH09176075A (en) 1997-07-08

Family

ID=18357576

Family Applications (1)

Application Number Title Priority Date Filing Date
JP34292495A Pending JPH09176075A (en) 1995-12-28 1995-12-28 Antimicrobial, antifungal and anti-inflammatory active substance and production thereof

Country Status (1)

Country Link
JP (1) JPH09176075A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2135515A1 (en) * 2008-06-20 2009-12-23 Firmenich Sa Taste enhancing compound

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2135515A1 (en) * 2008-06-20 2009-12-23 Firmenich Sa Taste enhancing compound

Similar Documents

Publication Publication Date Title
SU797591A3 (en) Method of preparing cc-1065 antibiotic
FR2885364A1 (en) ALKYL-, ALKENYL- AND ALKYNYLCARBAMATES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
CZ261493A3 (en) Pharmacologically active compounds, process of their preparation and pharmaceutical preparations in which they are comprised
FR2473519A1 (en) TERPENOIDS CONTAINING TWO FUNCTIONAL GROUPS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
JPH1045747A (en) Antimycin-a group compound mixture
JPH09176075A (en) Antimicrobial, antifungal and anti-inflammatory active substance and production thereof
JPH09176074A (en) Antimicrobial, antifungal and anti-inflammatory active substance and production thereof
US7541336B2 (en) Substance fki-1033 and process for producing the same
US3701787A (en) Preparation of 5,6-dihydro-5-hydroxy-6-propenyl-2-pyrone by fermentation and derivatives thereof
JPH06256278A (en) Optically active alpha-carbamoylalkanoic acid derivative and its production
EP0810198A1 (en) Sesquiterpene compounds
US8563266B2 (en) A-87774 compounds or salts thereof, production method thereof and agrochemicals containing the same as active ingredient
JP2764759B2 (en) Novel substance BT-38 substance, method for producing the same and antifungal agent containing the same as an active ingredient
FR2476128A1 (en) MICROBIOLOGICAL PROCESS FOR THE PRODUCTION OF NARASIN AND CROPS CONTAINING THE PRODUCING MICROORGANISM STREPTOMYCES LYDICUS DEBOER AND AL-
CH643298A5 (en) PROCESS FOR THE MANUFACTURE OF NEW ANTIBIOTICS.
JP2849832B2 (en) Antibiotic and method for producing the same
EP2519218B1 (en) Dibenzoyl peroxide derivatives, preparation method thereof and cosmetic or dermatological compositions containing same
EP0813537B1 (en) Phosphorylated nitrone derivatives, method for preparing same, and compositions containing said derivatives
JPH06184126A (en) Cyclic depsipeptide and its production
BE845520R (en) PENAM DERIVATIVES AND THEIR PREPARATION
JP4619570B2 (en) MB5747 substance and salt thereof, production method thereof, and agricultural and horticultural fungicide containing MB5747 substance or salt thereof as an active ingredient
JPS6351395A (en) Antibiotic sf-2415 and production thereof
JPH06245778A (en) Production of antimicrobial antifungal animal cell growth inhibitor
KR850000784B1 (en) Process for preparing pyrimidine derivatives
KR100646829B1 (en) Novel adenosine derivative and its salt, process for preparation, pharmaceutical composition comprising the same and use thereof

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Effective date: 20051116

Free format text: JAPANESE INTERMEDIATE CODE: A131

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20060308